Hospital
Vanderbilt Bedford Hospital, LLC
Vanderbilt Bedford Hospital, LLC was paid $4.41M by Medicaid between Jan 2021 and Dec 2024, across 90 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.
33Billing provider infoVANDERBILT BEDFORD HOSPITAL, LLC
SHELBYVILLE, TN 37160
SHELBYVILLE, TN 37160
33aNPI1487253449assigned 10/21/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.41M
24GClaims116,003
24DCodes billed90
24AFirst – last monthJan 2021 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#44 of 71
Median peer was paid$6.96M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SIMMONS, ANGELA controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 32,628 | $1.07M | |
| 2022 | 38,525 | $1.43M | |
| 2023 | 27,594 | $1.06M | |
| 2024incomplete | 17,256 | $861K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 8,897 | 7,585 | $1.44M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 9,141 | 8,446 | $1.22M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 3,576 | 3,028 | $750K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.8% | 3,220 | 2,982 | $300K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 3,545 | 2,881 | $111K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.5% | 2,407 | 651 | $108K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 1,092 | 1,065 | $75K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 1,801 | 1,647 | $66K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.4% | 1,057 | 991 | $60K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,407 | 2,906 | $43K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,221 | 3,008 | $33K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 379 | 365 | $31K |
78 more codes
| G0378 | Hospital observation service, per hour | <1% | 185 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,142 | $19K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 357 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,197 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,307 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 5,379 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,330 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 351 | $10K |
| 87631 | <1% | 520 | $10K | |
| 80061 | Lipid panel | <1% | 1,875 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 301 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 135 | $6K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 150 | $5K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 108 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 202 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 395 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,673 | $4K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 13 | $4K |
| 87400 | <1% | 535 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 178 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 62 | $865.46 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 46 | $814.04 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,425 | $545.55 |
| 85027 | <1% | 393 | $449.31 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,199 | $367.61 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 22 | $349.25 |
| 84439 | <1% | 142 | $307.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 832 | $275.88 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 751 | $226.03 |
| 84484 | <1% | 2,401 | $162.88 | |
| 80076 | <1% | 4,687 | $161.34 | |
| 87081 | <1% | 939 | $150.29 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 861 | $107.05 |
| 82607 | <1% | 48 | $94.55 | |
| 86403 | <1% | 468 | $85.40 | |
| 81001 | <1% | 3,187 | $65.11 | |
| 81003 | <1% | 1,333 | $64.62 | |
| 83690 | <1% | 1,880 | $63.94 | |
| 86803 | <1% | 12 | $61.74 | |
| 83540 | <1% | 29 | $56.15 | |
| 81025 | <1% | 1,778 | $55.38 | |
| 82728 | <1% | 15 | $49.10 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,336 | $45.84 |
| 83550 | <1% | 15 | $31.50 | |
| 83880 | <1% | 98 | $29.05 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 654 | $25.81 |
| 82550 | <1% | 220 | $20.19 | |
| 87807 | <1% | 195 | $9.69 | |
| 82150 | <1% | 240 | $9.60 | |
| 82553 | <1% | 84 | $8.55 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 548 | $5.74 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 301 | $3.77 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 373 | $2.76 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 863 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 13 | $0.00 |
| 85610 | 0% | 752 | $0.00 | |
| 87420 | 0% | 61 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 46 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 26 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 54 | $0.00 |
| 83735 | 0% | 222 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 1,138 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,800 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 321 | $0.00 |
| 85379 | 0% | 120 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 230 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 26 | $0.00 |
| J3490 | Unclassified drugs | 0% | 712 | $0.00 |
| 85730 | 0% | 216 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 278 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 235 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 88 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 20 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 13 | $0.00 |
| 87070 | 0% | 14 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 19 | $0.00 |
| 82962 | 0% | 54 | $0.00 | |
| 82077 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIMMONS, ANGELA (VP - FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Vanderbilt University Medical Center | Nashville, TN | $137.59M |
| Vanderbilt University Medical Center | Nashville, TN | $29.07M |
| Vanderbilt Coffee Hospital, LLC | Tullahoma, TN | $4.09M |
| Vanderbilt Bedford Hospital, LLC | Shelbyville, TN | $2.02M |
| Vanderbilt University Medical Center | Nashville, TN | $1.01M |
| Vanderbilt Bedford Hospital, LLC | Shelbyville, TN | $926K |
| Vanderbilt University Medical Center | Nashville, TN | $270K |
| Vanderbilt Bedford Hospital, LLC | Wartrace, TN | $157K |
| Vanderbilt Bedford Hospital, LLC | Shelbyville, TN | $127K |
| Vanderbilt Bedford Hospital, LLC | Unionville, TN | $123K |
| Vanderbilt University Medical Center | Nashville, TN | $27K |
| Vanderbilt Bedford Hospital, LLC | Shelbyville, TN | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.